pDR111_Bgal no NLS
(Plasmid
#188397)
-
PurposeExpresses beta-galactosidase via Phyper-spank which is optimized for Bacillus subtilis. There is a secretion peptide (PhoD) that is fused to beta-galactosidase.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 188397 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepDR111
- Backbone size w/o insert (bp) 7841
- Total vector size (bp) 11074
-
Modifications to backboneAddition of insert and fusion components to NheI site
-
Vector typeBacterial Expression
-
Selectable markersSpectinomycin for Bacillus subtilis
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namelacZ
-
Alt nameBeta-galactosidase
-
SpeciesEscherichia coli
-
Insert Size (bp)3072
- Promoter Phyper spank
-
Tag
/ Fusion Protein
- PhoD secretion peptide (N terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer cggTTATTTTTGACACCAGAC
- 3′ sequencing primer tcgagggtAAaTGTGAGCaCTC (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pDR111_Bgal no NLS was a gift from Christopher Contag (Addgene plasmid # 188397 ; http://n2t.net/addgene:188397 ; RRID:Addgene_188397) -
For your References section:
Engineered endosymbionts that alter mammalian cell surface marker, cytokine and chemokine expression. Madsen CS, Makela AV, Greeson EM, Hardy JW, Contag CH. Commun Biol. 2022 Aug 30;5(1):888. doi: 10.1038/s42003-022-03851-6. 10.1038/s42003-022-03851-6 PubMed 36042261